HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China flag China · Delayed Price · Currency is CNY
2.720
+0.010 (0.37%)
Jun 9, 2026, 3:04 PM CST

SHE:002437 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
663.65396.4481.96711.281,2381,496
Trading Asset Securities
284.08533.6630-50.56-
Cash & Short-Term Investments
947.73930.06511.96711.281,2881,496
Cash Growth
57.43%81.66%-28.02%-44.79%-13.87%67.04%
Accounts Receivable
138.46128.38128.62207.67236.82235.59
Other Receivables
27.0823.7318.8726.6536.5382.85
Receivables
165.54152.11147.49234.32273.35318.45
Inventory
206.7205.88188.67190.67214.14352.09
Other Current Assets
29.1430.8129.0618.1940.434.17
Total Current Assets
1,3491,319877.191,1541,8162,200
Property, Plant & Equipment
959.27985.511,0291,0591,1191,235
Long-Term Investments
250.1237.51277.56298.23458.25498.33
Goodwill
369.03369.03369.03369.03369.03411.16
Other Intangible Assets
154.5162.98166.66191.3221.18290.34
Long-Term Deferred Tax Assets
15.9616.5316.4621.0133.7724.19
Long-Term Deferred Charges
8.157.9714.458.239.717.21
Other Long-Term Assets
35.4736.274.7351.5846.6218.21
Total Assets
3,1423,1352,8253,1524,0744,695
Accounts Payable
79.2765.1360.4569.8875.48270.49
Accrued Expenses
15.97341.62395.46109.41516.94527.16
Short-Term Debt
20.0290.06-675.691,4551,558
Current Portion of Leases
1.391.381.33---
Current Income Taxes Payable
30.227.7110.239.6710.269.33
Current Unearned Revenue
24.0244.944.250.0383.1786.98
Other Current Liabilities
538.68247.05311.37496.47195.49226.24
Total Current Liabilities
709.56797.85823.031,4112,3362,678
Long-Term Leases
0.140.571.95---
Long-Term Unearned Revenue
12.1112.3212.9217.8721.4324.53
Long-Term Deferred Tax Liabilities
13.0613.1913.2812.1212.8712.55
Other Long-Term Liabilities
1.081.081.081.080.030.82
Total Liabilities
735.96825852.261,4422,3712,716
Common Stock
2,2302,2322,2802,1982,1982,198
Additional Paid-In Capital
413.68413.29456.81380.47471.13448.21
Retained Earnings
-209.61-304.54-680.75-913.51-1,034-742.51
Treasury Stock
-40.23-42.93-102.03---
Comprehensive Income & Other
-5.72-4.19-3.09-3.32-4.17-9.61
Total Common Equity
2,3882,2941,9511,6621,6311,894
Minority Interest
17.6415.922.1548.4672.384.7
Shareholders' Equity
2,4062,3101,9731,7101,7041,979
Total Liabilities & Equity
3,1423,1352,8253,1524,0744,695
Total Debt
21.5592.013.28675.691,4551,558
Net Cash (Debt)
926.18838.05508.6835.59-166.67-62.42
Net Cash Growth
75.06%64.75%1329.47%---
Net Cash Per Share
0.420.370.220.02-0.08-0.03
Filing Date Shares Outstanding
2,2302,2322,2802,1982,1982,198
Total Common Shares Outstanding
2,2302,2322,2802,1982,1982,198
Working Capital
639.5552154.16-256.7-520.11-477.9
Book Value Per Share
1.071.030.860.760.740.86
Tangible Book Value
1,8641,7621,4151,1011,0411,193
Tangible Book Value Per Share
0.840.790.620.500.470.54
Buildings
-1,2381,2331,2321,2391,310
Machinery
-794.32797.43807.63803.46801.97
Construction In Progress
-1.371.893.0512.891.8